# Non-Hodgkin Lymphoma and Tuberculosis Coexisting in the Same Cervical Lymph Node: A Case Report

**Authors:** Abdallah Taha, Sara Alzhrani, Nawaf Aljafari, Bashar A Aljadani, Abdullah Al-Rashdi, Abdulrahman A Almuntashiri, Khalid M Alkhalifah, Wafa Bahshwan

PMC · DOI: 10.7759/cureus.98957 · Cureus · 2025-12-11

## TL;DR

A 60-year-old woman had both lymphoma and tuberculosis in the same neck lymph node, requiring combined treatment for successful recovery.

## Contribution

This case report documents the rare coexistence of non-Hodgkin lymphoma and tuberculosis in a single cervical lymph node.

## Key findings

- The patient had diffuse large B-cell lymphoma confirmed by immunohistochemistry and tuberculous lymphadenitis confirmed by PCR and culture.
- Sequential treatment with anti-tuberculous therapy followed by R-CHOP chemotherapy led to complete remission.
- The case emphasizes the need to screen for lymphoma in patients with suspected tuberculous lymphadenitis.

## Abstract

We report the case of a 60-year-old female from Saudi Arabia who presented with a six-month history of a neck mass. Following an excisional biopsy under local anesthetic, laboratory analyses, including polymerase chain reaction (PCR), tuberculosis culture, and microscopic tissue examination, revealed the presence of diffuse large B-cell lymphoma (DLBCL) alongside tuberculous lymphadenitis in the cervical region. Immunohistochemistry confirmed DLBCL with CD20+, BCL6+, MUM1+, and Ki-67 80%. The patient was managed sequentially with anti-tuberculous therapy (ATT) followed by R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) regimen, achieving complete remission at six months with 12-month disease-free follow-up. This report highlights that lymphoma and tuberculous lymphadenitis can coexist. In patients undergoing lymph node biopsy for suspected tuberculosis, it is crucial to thoroughly assess for an underlying lymphoma. Detecting a malignancy in a cervical tuberculous lymph node significantly alters the therapeutic approach and requires coordinated management with medical oncology specialists.

## Linked entities

- **Chemicals:** cyclophosphamide (PubChem CID 2907), doxorubicin (PubChem CID 31703), vincristine (PubChem CID 5978), prednisone (PubChem CID 5865)
- **Diseases:** Non-Hodgkin Lymphoma (MONDO:0018908), Tuberculosis (MONDO:0018076), diffuse large B-cell lymphoma (MONDO:0018905)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** PWWP3A (PWWP domain containing 3A, DNA repair factor) [NCBI Gene 84939] {aka EXPAND1, HSPC211, MUM-1, MUM1}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, BCL6 (BCL6 transcription repressor) [NCBI Gene 604] {aka BCL5, BCL6A, LAZ3, ZBTB27, ZNF51}
- **Diseases:** lymphoma (MESH:D008223), neck mass (MESH:D006258), tuberculous lymphadenitis (MESH:D014388), Non-Hodgkin Lymphoma and (MESH:D008228), Tuberculosis (MESH:D014376), malignancy (MESH:D009369), tuberculous (MESH:D014390), DLBCL (MESH:D016403), Node (MESH:D012804)
- **Chemicals:** R-CHOP (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12790099/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12790099/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12790099/full.md

---
Source: https://tomesphere.com/paper/PMC12790099